Emergent BioSolutions Expands Smallpox Vaccine Approval to Combat Mpox After Restructuring and Facility Closures September 4, 2024 Emergent BioSolutions has received expanded approval from the U.S. Food and Drug Administration [….]
Global Collaboration and Industry’s Role in Combating the Mpox Outbreak
Published on :Global Collaboration and Industry’s Role in Combating the Mpox Outbreak Global health organizations and industry leaders like Bavarian Nordic and QIAGEN are collaborating to tackle the emerging mpox outbreak, with [….]